Mizuho Maintains Outperform on Surgery Partners, Lowers Price Target to $17
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $19 to $17.
Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $19 to $17.